4//SEC Filing
Schimmelpennink Evert B. 4
Accession 0001815776-25-000011
CIK 0001815776other
Filed
Mar 6, 7:00 PM ET
Accepted
Mar 7, 6:10 PM ET
Size
7.6 KB
Accession
0001815776-25-000011
Insider Transaction Report
Form 4
Schimmelpennink Evert B.
DirectorPresident, CEO and Secretary
Transactions
- Exercise/Conversion
Common Stock
2025-03-07$1.04/sh+4,200$4,368→ 49,200 total - Exercise/Conversion
Stock Option (right to buy)
2025-03-07−4,200→ 337,906 totalExercise: $1.04Exp: 2031-03-07→ Common Stock (4,200 underlying)
Footnotes (1)
- [F1]Shares issued pursuant to the LENZ Therapeutics Operations, Inc. (previously named Lenz Therapeutics, Inc.) 2020 Equity Incentive Plan (the "2020 Plan"). Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2020 Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one (1) year anniversary of the Vesting Commencement Date, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean March 8, 2021.
Documents
Issuer
LENZ Therapeutics, Inc.
CIK 0001815776
Entity typeother
Related Parties
1- filerCIK 0001713795
Filing Metadata
- Form type
- 4
- Filed
- Mar 6, 7:00 PM ET
- Accepted
- Mar 7, 6:10 PM ET
- Size
- 7.6 KB